Low-dose methotrexate action plan
Rheumatoid arthritis (RA) and psoriatic arthritis (PsA) are long-term conditions where the body’s immune system mistakenly attacks healthy tissues such as the joints and skin. This causes inflammation, leading to symptoms such as joint pain and swelling. Use this action plan to discuss methotrexate with your rheumatologist and plan the best way to take your medicine.
This Low-dose methotrexate action plan has been developed with NPS MedicineWise and seven other organisations representing specialists, pharmacists, consumers and research experts, which form the Targeted Therapies Alliance. The Alliance provides stewardship and direction about the safe and wise use of biological disease-modifying antirheumatic drugs (bDMARDs) and other specialised medicines. Additional inflammatory arthritis resources for consumers can be found here: https://www.nps.org.au/bdmards/rheumatology/consumers#consumers
What is accessible design?
Find out about what accessible design is and about the Accessible Design Division.
Programs & Research
Arthritis Australia funds research and advocates to improve care, management, support and quality-of-life for people with arthritis.
Advocacy & policy
Arthritis Australia advocates to government, business, industry and community leaders to improve care, management, support and quality of life for people with arthritis.
Sign up to Arthritis Insights
Regular updates, news and research findings delivered to your inbox: